Revolution Medicines

RVMD

0 Followers

$41.91

+11.29%

$4.25

6 August

Upcoming Earnings

Market Cap.

P/E

Overview Metrics Financials

RVMD Fair Price

$90.52

Overvalued by 93.0%

To display the fair price of a share, you need to be a member of Bulios Black.

My Notes

Začít psát

Profile

Revolution Medicines is a U.S.-based biotechnology company focused on developing innovative cancer therapies targeting specific proteins and signaling pathways associated with cancer development. The company specializes in identifying and modulating new therapeutic targets, particularly oncogenic proteins that are key to the growth and spread of cancer cells. Revolution Medicines concentrates on developing drugs that could offer a new approach to cancer treatment and improve outcomes for patients suffering from various types of cancer.

Feed

There are no posts to show right now.